Vor Biopharma

(NASDAQ) VOR

Current Price$16.12

Market Cap$785.47M

Since IPO (2021)-98%

5 Year-97%

1 Year+50%

1 Month-5%

Vor Biopharma Financials at a Glance

Market Cap

$785.47M

Revenue (TTM)

$0.00

Net Income (TTM)

$695.98M

EPS (TTM)

$-333.58

P/E Ratio

-0.05

Dividend

$0.00

Beta (Volatility)

1.13 (Average)

Dividend

$0.00

Beta (Volatility)

1.13 (Average)

Price

$16.12

Volume

1,521

Open

$15.97

Price

$16.12

Volume

1,521

Open

$15.97

Previous Close

$16.08

Daily Range

$15.95 - $16.13

52-Week Range

$2.62 - $65.80

Dividend

$0.00

Beta (Volatility)

1.13 (Average)

Price

$16.12

Volume

1,521

Open

$15.97

Previous Close

$16.08

Daily Range

$15.95 - $16.13

52-Week Range

$2.62 - $65.80

VOR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Vor Biopharma

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Jean-Paul Kress, MD

Website

www.vorbio.com

Headquarters

Cambridge, MA 02140, US

VOR Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-125%

Return on Capital

-85%

Return on Assets

-1%

Earnings Yield

-20.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$785.47M

Shares Outstanding

48.85M

Volume

1.52K

Avg. Volume

976.91K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$371.64M

EBITDA

$368.75M

Operating Cash Flow

$142.71M

Capital Expenditure

$941.00K

Free Cash Flow

$143.65M

Cash & ST Invst.

$455.21M

Total Debt

$3.00M

Vor Biopharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$23.00K

+97.3%

Gross Margin

0.00%

N/A

Market Cap

$785.47M

N/A

Market Cap/Employee

$4.94M

N/A

Employees

159

N/A

Net Income

$1.72B

+5709.7%

EBITDA

$35.94M

-20.4%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$452.21M

+652.5%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$2.72M

-90.2%

Short Term Debt

$280.00K

-93.4%

Return on Assets

-1.50%

N/A

Return on Invested Capital

-84.67%

N/A

Free Cash Flow

$23.11M

+4.2%

Operating Cash Flow

$22.80M

+5.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

FBRXForte Biosciences, Inc.

FBRXForte Biosciences, Inc.$25.76-1.56%

FATEFate Therapeutics, Inc.

FATEFate Therapeutics, Inc.$2.34-3.70%

ALECAlector, Inc.

ALECAlector, Inc.$2.26-7.38%

NKTXNkarta, Inc.

NKTXNkarta, Inc.$3.22+2.22%

SPROSpero Therapeutics, Inc.

SPROSpero Therapeutics, Inc.$2.51+0.17%

PEPGPepGen Inc.

PEPGPepGen Inc.$1.79+0.56%

ANIXAnixa Biosciences, Inc.

ANIXAnixa Biosciences, Inc.$2.96-0.17%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.47+0.07%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$45.73+0.00%

NOKNokia

NOKNokia$12.35-0.06%

POETPoet Technologies

POETPoet Technologies$9.58-0.01%

IRENIren

IRENIren$65.17+0.15%

SNAPSnap

SNAPSnap$5.98-0.02%

ACHRArcher Aviation

ACHRArcher Aviation$6.28-0.02%

Questions About VOR

What is the current price of Vor Biopharma?

Vor Biopharma is trading at $16.12 per share.

What is the 52-week range for Vor Biopharma?

Over the past 52 weeks, Vor Biopharma has traded between $2.62 and $65.80.

How much debt does Vor Biopharma have?

As of the most recent reporting period, Vor Biopharma reported total debt of $3.00M.

How much cash does Vor Biopharma have on hand?

Vor Biopharma reported $396.49M in cash and cash equivalents in its most recent financial results.

What is Vor Biopharma’s dividend yield?

Vor Biopharma does not currently have a dividend yield.

Vor Biopharma

Vor Biopharma Financials at a Glance

VOR News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Vor Biopharma

VOR Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Vor Biopharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About VOR

What is the current price of Vor Biopharma?

What is the 52-week range for Vor Biopharma?

How much debt does Vor Biopharma have?

How much cash does Vor Biopharma have on hand?

What is Vor Biopharma’s dividend yield?

Premium Investing Services